Anergis' Series A Round

Anergis raised a round of funding on March 28, 2011.

Anergis is a clinical-stage biopharmaceutical company based in Switzerland. Anergis discovers and develops synthetic allergy vaccines with the aim to provide allergy patients and doctors with a signif…

Articles about Anergis' Series A Round: